Alvotech shares rise after FDA accepts review for Crohn’s drug
Alvotech shares rose after the FDA accepted AVT80 for review for a Crohn’s treatment.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.